首页 | 本学科首页   官方微博 | 高级检索  
     


The New Era of Hepatitis C: Therapy in Liver Transplant Recipients
Affiliation:1. Banner Transplant Institute, 1441 North 12th Street, Second floor, Phoenix, AZ 85006, USA;2. Banner University Medical Center Phoenix, Phoenix, AZ, USA;3. Servicio de Medicina Digestivo (Torre F-5), La Fe University Hospital, Ciberehd*, University of Valencia, Avda Fernando Abril Martorell n 106, Valencia 46026, Spain;1. Liver Unit, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Italy;2. Johann Wolfgang Goethe University Medical Center, Frankfurt am Main, Germany;3. Internal Medicine Clinica “Mater Dei”, Bari, Italy;4. Infectious Diseases Unit, Presidio ospedaliero Madonna delle Grazie, Matera, Italy;5. Medical Clinic “A. Murri”, Policlinico di Bari, Italy;6. Gastroenterology Unit, Ospedale Valduce, Como, Italy;7. Infectious Diseases Unit, Ospedale “Vito Fazzi”, Lecce, Italy;8. Interventional ultrasound Unit, Ospedale “Perrino”, Brindisi, Italy;9. Infectious Diseases Unit, Presidio Opedaliero Bisceglie, Italy;10. Medizinische Klinik 1, Goethe University Hospital, Frankfurt, Germany;11. Biostatic Unit, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Italy;1. Division of Transplantation, Department of Surgery, The Ohio State University Wexner Medical Center, 395 West 12th Avenue, Suite 100, Columbus, OH 43210, USA;2. Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, 395 West 12th Avenue, Suite 200, Columbus, OH 43210, USA
Abstract:
Keywords:Hepatitis C virus  Direct antiviral agents  Cirrhosis  Hepatocellular carcinoma  Liver transplant  Drug-drug interactions  Anti-HCV–positive donors  Waiting list
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号